AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a very strong health care provider.
在CNBC的“Halftime Report Final Trades”中，Cerity Partners 的Jim Lebenthal表示AbbVie Inc. (NYSE:ABBV) 是一家非常強大的醫療保健服務提供商。
On July 25, AbbVie reported second-quarter adjusted EPS of $2.65, down 8.9% year over year, beating the consensus of $2.57. Net revenues reached $14.46 billion, up 4.3%, beating the consensus of $14.03 billion. Sales were up 5.6% on an operational basis.
7月25日，AbbVie報告了第二季度調整後的每股收益爲2.65美元，同比下降8.9%，高於市場預期的2.57美元，淨營業額達到144.6億美元，同比增長4.3%，超過了市場預期的140.3億美元。業務運營基礎上，銷售額增長了5.6%。
Stephen Weiss of Short Hills Capital Partners said Leidos Holdings, Inc. (NYSE:LDOS) reported stable earnings.
Short Hills Capital Partners的Stephen Weiss表示Leidos Holdings，Inc. (NYSE:LDOS) 公佈了穩定的收益。
On July 30, Leidos reported better-than-expected second-quarter fiscal 2024 earnings. The company posted revenue growth of 8% year-over-year to $4.13 billion, beating the analyst consensus estimate of $4.06 billion, driven by demand across all customer segments, especially for managed health services.
7月30日，Leidos報告了超出預期的2024財年第二季度收益。公司公佈了業務增長，同比增長了8%至41.3億美元，超過了分析師一致預估的40.6億美元，需求跨所有客戶領域增長，尤其是在醫療服務管理方面。
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
Stephanie Link of Hightower named iShares U.S. Healthcare ETF (NYSE:IYH) as her final trade.
Hightower的Stephanie Link選擇了ishares安碩美國醫療保健ETF（NYSE：IYH）作爲她的最後一筆交易。
Joseph M. Terranova of Virtus Investment Partners picked KKR & Co. Inc. (NYSE:KKR).
Virtus Investment Partners的Joseph m. Terranova選擇了KKR & Co. Inc. (NYSE:KKR)。
On July 31, KKR & Co posted second-quarter earnings of 72 cents per share on sales of $4.17 billion. On Aug. 2, Citigroup analyst Chris Allen maintained KKR with a Buy rating, while raising the price target from $130 to $150.
7月31日，KKR & Co發佈了每股收益爲72美分、銷售額爲41.7億美元的二季度收益。8月2日，花旗集團分析師Chris Allen 給予KKR買入評級，並將價格目標從130美元上調至150美元。
Price Action:
價格行動：
- AbbVie shares fell 2.6% to close at $184.36 on Monday.
- Leidos gained 0.9% during Friday's session.
- iShares U.S. Healthcare ETF fell 2.6% during Monday's session.
- KKR shares fell 2.2% to settle at $106.23 on Monday.
- AbbVie股價週一下跌2.6%，收於184.36美元。
- Leidos在週五交易中上漲了0.9%。
- ishares安碩美國醫療保健ETF在週一交易中下跌了2.6%。
- KKR股價週一下跌2.2%，收於106.23美元。
- Top 3 Tech Stocks That Could Surge This Quarter
- 本季可能上漲的前3家科技股
Image created using artificial intelligence via Midjourney.
圖像由Midjourney通過人工智能創建。